vs

Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and PAR TECHNOLOGY CORP (PAR). Click either name above to swap in a different company.

PAR TECHNOLOGY CORP is the larger business by last-quarter revenue ($120.1M vs $70.9M, roughly 1.7× Adaptive Biotechnologies Corp). On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 14.4%). Over the past eight quarters, PAR TECHNOLOGY CORP's revenue compounded faster (30.9% CAGR vs 28.1%).

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

PAR Technology Corp is a global provider of point-of-sale systems, restaurant management software, and integrated tech solutions. Its core segments serve food service, hospitality, and government security markets, offering cloud tools to streamline operations, enhance customer experiences, and boost efficiency for enterprise and small-to-medium clients.

ADPT vs PAR — Head-to-Head

Bigger by revenue
PAR
PAR
1.7× larger
PAR
$120.1M
$70.9M
ADPT
Growing faster (revenue YoY)
ADPT
ADPT
+20.8% gap
ADPT
35.1%
14.4%
PAR
Faster 2-yr revenue CAGR
PAR
PAR
Annualised
PAR
30.9%
28.1%
ADPT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ADPT
ADPT
PAR
PAR
Revenue
$70.9M
$120.1M
Net Profit
$3.4M
Gross Margin
73.6%
41.2%
Operating Margin
-27.1%
-15.0%
Net Margin
4.7%
Revenue YoY
35.1%
14.4%
Net Profit YoY
EPS (diluted)
$-0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADPT
ADPT
PAR
PAR
Q1 26
$70.9M
Q4 25
$71.7M
$120.1M
Q3 25
$94.0M
$119.2M
Q2 25
$58.9M
$112.4M
Q1 25
$52.4M
$103.9M
Q4 24
$47.5M
$105.0M
Q3 24
$46.4M
$96.8M
Q2 24
$43.2M
$78.2M
Net Profit
ADPT
ADPT
PAR
PAR
Q1 26
$3.4M
Q4 25
$-13.6M
Q3 25
$9.5M
$-18.2M
Q2 25
$-25.6M
$-21.0M
Q1 25
$-29.9M
$-24.4M
Q4 24
$-33.7M
Q3 24
$-32.1M
$-19.8M
Q2 24
$-46.2M
$54.2M
Gross Margin
ADPT
ADPT
PAR
PAR
Q1 26
73.6%
Q4 25
74.6%
41.2%
Q3 25
80.7%
41.3%
Q2 25
69.4%
45.4%
Q1 25
67.6%
46.5%
Q4 24
62.0%
42.9%
Q3 24
64.1%
44.5%
Q2 24
55.3%
41.0%
Operating Margin
ADPT
ADPT
PAR
PAR
Q1 26
-27.1%
Q4 25
-17.8%
-15.0%
Q3 25
10.9%
-14.8%
Q2 25
-42.5%
-15.4%
Q1 25
-56.4%
-15.2%
Q4 24
-71.3%
-15.6%
Q3 24
-70.3%
-15.7%
Q2 24
-109.6%
-26.5%
Net Margin
ADPT
ADPT
PAR
PAR
Q1 26
4.7%
Q4 25
-18.9%
Q3 25
10.2%
-15.3%
Q2 25
-43.5%
-18.7%
Q1 25
-56.9%
-23.4%
Q4 24
-71.0%
Q3 24
-69.1%
-20.5%
Q2 24
-107.0%
69.3%
EPS (diluted)
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
$-0.08
$-0.52
Q3 25
$0.06
$-0.45
Q2 25
$-0.17
$-0.52
Q1 25
$-0.20
$-0.60
Q4 24
$-0.22
$-0.56
Q3 24
$-0.22
$-0.56
Q2 24
$-0.31
$1.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADPT
ADPT
PAR
PAR
Cash + ST InvestmentsLiquidity on hand
$77.6M
$80.1M
Total DebtLower is stronger
$394.0M
Stockholders' EquityBook value
$825.1M
Total Assets
$505.9M
$1.4B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADPT
ADPT
PAR
PAR
Q1 26
$77.6M
Q4 25
$70.5M
$80.1M
Q3 25
$55.0M
$93.0M
Q2 25
$43.2M
$85.7M
Q1 25
$50.6M
$92.2M
Q4 24
$47.9M
$108.6M
Q3 24
$38.1M
$118.4M
Q2 24
$59.8M
$142.5M
Total Debt
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
$394.0M
Q3 25
$393.4M
Q2 25
$392.8M
Q1 25
$392.3M
Q4 24
$368.4M
Q3 24
$466.7M
Q2 24
$378.7M
Stockholders' Equity
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
$218.8M
$825.1M
Q3 25
$204.4M
$838.0M
Q2 25
$179.7M
$859.1M
Q1 25
$190.4M
$852.0M
Q4 24
$202.7M
$871.7M
Q3 24
$223.8M
$692.7M
Q2 24
$241.6M
$588.3M
Total Assets
ADPT
ADPT
PAR
PAR
Q1 26
$505.9M
Q4 25
$512.7M
$1.4B
Q3 25
$490.6M
$1.4B
Q2 25
$496.6M
$1.4B
Q1 25
$510.9M
$1.4B
Q4 24
$539.4M
$1.4B
Q3 24
$558.5M
$1.3B
Q2 24
$584.9M
$1.1B
Debt / Equity
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
0.48×
Q3 25
0.47×
Q2 25
0.46×
Q1 25
0.46×
Q4 24
0.42×
Q3 24
0.67×
Q2 24
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADPT
ADPT
PAR
PAR
Operating Cash FlowLast quarter
$-11.8M
Free Cash FlowOCF − Capex
$-12.5M
FCF MarginFCF / Revenue
-10.4%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-30.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
$2.1M
$-11.8M
Q3 25
$-7.1M
$8.4M
Q2 25
$-12.4M
$-6.6M
Q1 25
$-28.5M
$-17.2M
Q4 24
$-12.5M
$3.4M
Q3 24
$-27.1M
$8.8M
Q2 24
$-17.3M
$-13.8M
Free Cash Flow
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
$1.4M
$-12.5M
Q3 25
$-7.5M
$7.0M
Q2 25
$-13.1M
$-7.4M
Q1 25
$-29.7M
$-17.6M
Q4 24
$-12.6M
$3.2M
Q3 24
$-27.4M
$8.4M
Q2 24
$-19.0M
$-14.2M
FCF Margin
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
2.0%
-10.4%
Q3 25
-8.0%
5.9%
Q2 25
-22.2%
-6.6%
Q1 25
-56.7%
-16.9%
Q4 24
-26.5%
3.0%
Q3 24
-59.0%
8.7%
Q2 24
-44.1%
-18.2%
Capex Intensity
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
0.9%
0.7%
Q3 25
0.4%
1.1%
Q2 25
1.1%
0.7%
Q1 25
2.4%
0.4%
Q4 24
0.2%
0.2%
Q3 24
0.7%
0.4%
Q2 24
4.0%
0.5%
Cash Conversion
ADPT
ADPT
PAR
PAR
Q1 26
Q4 25
Q3 25
-0.75×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADPT
ADPT

Segment breakdown not available.

PAR
PAR

Subscription Service$76.1M63%
Hardware$27.8M23%
Professional Service$16.2M13%

Related Comparisons